Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-04
2010-12-14
Romeo, David S (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000
Reexamination Certificate
active
07851449
ABSTRACT:
The invention is related to the medicinal means of correction of metabolic vascular syndrome and diseases, associated with disordered vascular wall permeability and capillaries fragility, and can be used as a means of enhancing capillaries resistance. There is proposed a peptide lysyl-glutamyl-asparagine acid of the general formula H-Lys-Glu-Asp-OH sequence 1 [SEQ ID NO:1], revealing biological activity and capable of enhancing capillaries resistance. There is also proposed a pharmaceutical composition enhancing capillaries resistance, containing effective amount of peptide lysyl-glutamyl-asparagine acid of the general formula H-Lys-Glu-Asp-OH sequence 1 [SEQ ID NO: 1] as its active base and pharmaceutically acceptable carrier. This pharmaceutical composition is in form for parenteral administration. There is proposed a method for prevention and/or treatment of disorders of microcirculation in organs and tissues, consisting in the administration to a patient of the pharmaceutical composition, containing peptide lysyl-glutamyl-asparagine acid of the general formula H-Lys-Glu-Asp-OH sequence 1 [SEQ ID NO: 1] in the dose of 0.01-100 μg/kg of body weight at least once a day during a period necessary for attaining the therapeutic effect, such administration being performed parenterally.
REFERENCES:
patent: 6727227 (2004-04-01), Khavinson et al.
patent: WO 01/47950 (2001-07-01), None
patent: WO 2005/056580 (2005-06-01), None
patent: WO 2006/001728 (2006-01-01), None
patent: WO 2007/136295 (2007-11-01), None
patent: WO 2007/139431 (2007-12-01), None
patent: WO 2007/139435 (2007-12-01), None
Mileusnic, R. et al., “The Peptide Sequence Arg-Glu-Arg, Present in the Amyloid Precursor Protein, Protects Against Memory Loss Caused by Abeta and Acts as a Cognitive Enhancer” European Journal of Neuroscience, Apr. 2004, pp. 1933-1938, vol. 19, No. 7, Oxford University Press, Great Britain.
Khavinson, V Kh. et al., “Mechanisms Underlaying Geroprotective Effects of Peptides” Bulletin of Experimental Biology and Medicine, Jan. 2002, pp. 1-5, vol. 133, No. 1, Consultants Bureau, New York, NY.
Korkushko O. V. et al., “Geroprotective Effect of Epithalamine (Pineal Gland Peptide Preparation) in Elderly Subjects with Accelerated Aging” Bulletin of Experimental Biology and Medicine, Sep. 1, 2006, pp. 356-359, vol. 142, No. 3, Kluwer Academic Publishers, NE.
Wang Chao et al., “The Synthesis and Immunosuppressive Activities of Steroid-urotoxin Linkers” Bioorganic & Medicinal Chemistry, Aug. 15, 2004, pp. 4403-4421, vol. 12, No. 16.
Barabanova, S.V. et al., “[Parallel Analysis of C-Fos Protein and Interleukin-2 Expression in Hypothalmic Cells Under Different Influence]” Feb. 2007, pp. 150-160, vol. 92, No. 2, Rossi §SKII Fiziologicheski § Zhurnal Imeni I.M. Sechenova, Rossi §Skaia Akademiia Nauk.
Sibarov, D.A. et al., “Epitalon Influences Pineal Secretion in Stress-Exposed Rats in the Daytime” Neuroendocrinology Letters, 2002, pp. 452-454, vol. 23, No. 5-6, Sweden.
Grigoriev Evgeny Iosifovich
Khavinson Vladimir Khatskelevich
Malinin Vladimir Victorovich
Ryzhak Galina Anatolievna
Leydig , Voit & Mayer, Ltd.
Obschestvo S Ogranichennoi Otvetstvennostyu “SIA Peptides
Romeo David S
LandOfFree
Peptide, pharmaceutical composition, and a method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide, pharmaceutical composition, and a method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide, pharmaceutical composition, and a method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4169543